Amplification of the α-type PDGFR (PDGFRA) gene is found in 15% of all tumors, mainly in the PN subtype of GBM [45,61] and approximately 40% of tumors harboring gene amplification contain an intragenic deletion in this gene [62]. This evidence concerns the gene PDGFRA and glioblastoma.